A Personal Cancer Vaccine (NEO-PV-01) and APX005M or Ipilimumab With Nivolumab in Patients With Advanced Melanoma
Clinical trial NCT03597282 · TERMINATED
Trial details
- NCT number
- NCT03597282
- Sponsor
- BioNTech US Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-08
- Primary completion
- 2020-05-05
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.